Carfilzomib in combination with R-CHOP for initial treatment of patients with non-germinal center diffuse large B-cell lymphoma: a multicenter, single arm, phase 1/2 study.
Saved in:
| Title: | Carfilzomib in combination with R-CHOP for initial treatment of patients with non-germinal center diffuse large B-cell lymphoma: a multicenter, single arm, phase 1/2 study. |
|---|---|
| Authors: | Hill BT; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Torka P; Roswell Park Comprehensive Cancer Centre, Buffalo, NY, USA., Hernandez-Ilizaliturri F; Roswell Park Comprehensive Cancer Centre, Buffalo, NY, USA., Dean R; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Jagadeesh D; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Karamlou K; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Fu CL; Cleveland Clinic Florida, Weston, FL, USA., Winter AM; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Ahmed W; Cleveland Clinic Florida, Weston, FL, USA., Smith M; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Mejia Garcia A; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Cooper B; University Hospitals, Cleveland Medical Center, Cleveland, OH, USA., Krauspe E; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Zhou J; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Brooks T; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Kacar M; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Thomas J; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Li H; Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA., Jia XS; Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA., Chen Y; Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA., Caimi P; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2025 Sep; Vol. 66 (9), pp. 1700-1709. Date of Electronic Publication: 2025 May 21. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Multicenter Study; Clinical Trial, Phase I |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2025.2504156 |
